Curasight AS (CURAS)

Currency in DKK
3.31
-0.03(-0.90%)
Closed·
CURAS Scorecard
Full Analysis
Stock has taken a big hit over the last week
CURAS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.133.50
52 wk Range
1.8013.40
Key Statistics
Bid/Ask
3.15 / 3.29
Prev. Close
3.34
Open
3.23
Day's Range
3.13-3.5
52 wk Range
1.8-13.4
Volume
69.75K
Average Volume (3m)
138.31K
1-Year Change
-64.99%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CURAS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell

Curasight AS Company Profile

Curasight A/S develops therapeutic and diagnostic solutions for the treatment of cancer. It develops uTREAT therapeutic solutions, which are in the pre-clinical stage to treat glioblastoma (brain cancer), as well as have completed the pre-clinical stage for the treatment of non-small cell lung cancers, neuroendocrine neoplasms, head and neck cancer, and pancreatic cancers. The company also develops uTRACE diagnostic solutions, which are in Phase II to treat prostate cancer, as well as have completed Phase II for the treatment of glioblastoma (brain cancer), prostate cancer, neuroendocrine neoplasms, head and neck cancer, non-small cell lung cancer, and urinary bladder cancer. Curasight A/S was incorporated in 2013 and is based in Copenhagen, Denmark.

Compare CURAS to Peers and Sector

Metrics to compare
CURAS
Peers
Sector
Relationship
P/E Ratio
−4.5x−2.4x−0.5x
PEG Ratio
0.61−0.080.00
Price/Book
61.1x1.4x2.6x
Price / LTM Sales
-26.4x3.3x
Upside (Analyst Target)
136.7%375.7%42.8%
Fair Value Upside
Unlock0.2%6.5%Unlock

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-0.25 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CURAS Income Statement

FAQ

What Stock Exchange Does Curasight AS Trade On?

Curasight AS is listed and trades on the Spotlight Stock Market stock exchange.

What Is the Stock Symbol for Curasight AS?

The stock symbol for Curasight AS is "CURAS."

What Is the Curasight AS Market Cap?

As of today, Curasight AS market cap is 153.20M.

What Is Curasight AS's Earnings Per Share (TTM)?

The Curasight AS EPS (TTM) is -1.59.

When Is the Next Curasight AS Earnings Date?

Curasight AS will release its next earnings report on 27 Aug 2025.

From a Technical Analysis Perspective, Is CURAS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Curasight AS Stock Split?

Curasight AS has split 0 times.

How Many Employees Does Curasight AS Have?

Curasight AS has 4 employees.

What is the current trading status of Curasight AS (CURAS)?

As of 06 Aug 2025, Curasight AS (CURAS) is trading at a price of 3.31, with a previous close of 3.34. The stock has fluctuated within a day range of 3.13 to 3.50, while its 52-week range spans from 1.80 to 13.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.